Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%

MT Newswires Live

Oct 27

Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.

Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.

Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.

The agreement allows the company to continue using the "Xinhua" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2578774660"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2578774660\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2578774660?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-27 11:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578774660","market":"hk","top_or_hot":-1,"title":"Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with <a href=\"https://laohu8.com/S/000756\">Shandong Xinhua</a> Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.</p><p>Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.</p><p>The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-27 11:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with <a href=\"https://laohu8.com/S/000756\">Shandong Xinhua</a> Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.</p><p>Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.</p><p>The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2578774660","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578774660","pubTimestamp":1761535144,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shandong Xinhua Pharmaceutical  said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","BK1515":"抗疫概念","00719":"山东新华制药股份","000756":"新华制药","BK0239":"医药制造","BK0164":"国企混改"},"translate_title":"山东新华制药与华录续签商标许可；股价下跌3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000756":0.9,"00719":0.9},"content_text":"Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}